Apotex Can Pursue $60M Fee In BMS, Aventis Dispute: Court
A New Jersey appellate court on Thursday reversed summary judgment for Sanofi-Aventis and Bristol-Myers Squibb Co. on Apotex Inc.'s claim that it's owed $60 million under a patent litigation settlement, finding...To view the full article, register now.
Already a subscriber? Click here to view full article